Anti-VEGF Benefits All AMD Eyes

A study has shown that intravitreal ranibizumab injections for neovascular age-related macular degeneration yielded similar outcomes in phakic and pseudophakic eyes. Phakic and pseudophakic patients...
April 26, 2013 12:00 pm

A study has shown that intravitreal ranibizumab injections for neovascular age-related macular degeneration yielded similar outcomes in phakic and pseudophakic eyes.[/vc_column_text][/vc_column]

Phakic and pseudophakic patients received three monthly loading dose injections of ranizibumab and were then treated on an as needs basis.

At final follow-up, mean BCVA was 0.75 in the phakic group and 0.74 in the pseudophakic group. Both improvements were statistically significant. Central macular thickness decreased significantly in both groups.

Login
Log in below to access your courses.
Log In With Google
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.